"Especially in the case of strokes, where the blood supply to the brain is interrupted, there is often an extracellular increase in the excitatory neurotransmitter glutamate, which severely ...

DelveInsight's "XADAGO/EQUFINA Market Size, Forecast, and Market Insight Report" highlights the details around XADAGO/EQUFINA ...

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

A genetic predisposition may explain the enormous variability of this phenomenon, of which up to 47 symptoms have been ...

A newly discovered brain circuit links motion sickness with metabolism, offering potential for obesity treatments. Motion ...

Methyl eugenol (ME), a phenylpropanoid compound found in the essential oils of various aromatic plants, has recently garnered attention due to its ...

Outside magazine The idea behind sleepmaxxing — getting sufficient, good quality sleep — isn’t new, says Aruna Rao, assistant professor of neurology at Johns Hopkins Medicine. “People are finally ...

It is the second drug in the PD-1/PD-L1 inhibitor class to be cleared in a subcutaneous injection form by the FDA after Roche's Tecentriq Hybreza (atezolizumab and hyaluronidase) – which got a ...

The supplement is available in tablet form. One pack of GenF20 Plus contains 120 tablets. The manufacturer recommends ...

AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for giant cell arteritis.